Literature DB >> 10912629

Diseases of the pleura: the use of talc for pleurodesis.

R W Light.   

Abstract

Talc either insufflated (poudrage) or in a suspension (slurry) is commonly used to create a pleurodesis in patients with recurrent pneumothorax or recurrent pleural effusions. There are now at least 32 cases in the literature in which patients developed the acute respiratory distress syndrome after receiving talc intrapleurally. The mechanism for the development of acute respiratory distress syndrome after the intrapleural administration of talc is not known, but it may be related to the systemic absorption of talc. Since there are effective alternatives to talc for producing pleurodesis (mechanical abrasion if thoracoscopy is performed; tetracycline derivatives or bleomycin if chest tubes are used), intrapleural talc should not be used to produce a pleurodesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10912629     DOI: 10.1097/00063198-200007000-00001

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  4 in total

1.  Hemoptysis following Talc Pleurodesis in a Pneumothorax Patient.

Authors:  Yusuke Kakiuchi; Fumihiro Yamaguchi; Makoto Hayashi; Yusuke Shikama
Journal:  Case Rep Pulmonol       Date:  2017-10-16

2.  Risk factors related to pleural empyema after talc slurry pleurodesis.

Authors:  Paula Duarte D'Ambrosio; Pedro Henrique Xavier Nabuco de Araújo; Eserval Rocha Junior; Mauro Razuk Filho; Paulo Manuel Pêgo-Fernandes; Ricardo Mingarini Terra
Journal:  Clinics (Sao Paulo)       Date:  2022-08-27       Impact factor: 2.898

3.  Comparisons of doxycycline solution with talc slurry for chemical pleurodesis and risk factors for recurrence in South Korean patients with spontaneous pneumothorax.

Authors:  Eun Ha Park; Joo Hee Kim; Jeong Yee; Jee Eun Chung; Jong Mi Seong; Hyen Oh La; Hye Sun Gwak
Journal:  Eur J Hosp Pharm       Date:  2018-04-18

4.  Comparison of Hydroxyethyl starch 130/0.4 (6%) with commonly used agents in an experimental Pleurodesis model.

Authors:  Hasan Oğuz Kapicibasi; Hasan Ali Kiraz; Nazli Demir Gök
Journal:  BMC Pulm Med       Date:  2020-08-27       Impact factor: 3.317

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.